-
The RRDi Legal Disclaimer explains why we do not allow commercial links for now but here are a few links in case you need information on rosacea.
NIH/NIAMS Questions and Answers About Rosacea
(The NIH spends over $31 Billion dollars on research and very little if any on rosacea research - for more information)If you have no idea what rosacea looks like, it looks like acne. You may find hundreds of images of rosacea in a Google Search.
Comparing Non Profit Organizations with their Mission
Other Non Profit Rosacea OrganizationsAmerican Acne and Rosacea Society (AARS) 501 (c) (3) non-profit
(Spends most of it donations on conventions for its prestigious members and very little on rosacea research)Acne and Rosacea Society of Canada
(Absolutely no financial public records so we have no data on any rosacea research)
National Rosacea Society (NRS) 501 (c) (3) non-profit
(Spends 60% of its donations on two private contractors owned by the director/president of the NRS, Sam Huff, and 10% of its donations on rosacea research)
Rosacea Research Foundation [DISSOLVED]
(Spent $16K of its donations to the NRS)Other Non Profit Organizations
The American Academy of Dermatology
(Spent 3% in 2015 on research [very little if any on rosacea research] and spent most of its donations on employee salaries/benefits and payroll taxes and the second largest expence on sponsoring conventions for dermatologists)
-
Posts
-
Related Articles Cutaneous pseudolymphoma with rhinophyma-like lesion. J Dermatol. 2019 09;46(9):e335-e337 Authors: Oginezawa M, Kawai K PMID: 30951205 [PubMed - indexed for MEDLINE] {url} = URL to article -
Related Articles Topical treatments for rosacea. Can Fam Physician. 2019 Nov;65(11):803 Authors: Fritsch P, Kolber MR, Korownyk C PMID: 31722913 [PubMed - in process] {url} = URL to article
-
Related Articles [Rhinophyma, management methods and oncological risk]. Rev Med Liege. 2019 Nov;74(11):606-610 Authors: Bachelet JT, Delafond C, Buchholzer S, Modaressi SA, Nizet C, Termont A Abstract Rhinophyma is the most advanced stage of rosacea (stage IV). It is a benign lesion but aesthetically disabling. We present through a major case of rhinophyma and a review of the literature the diagnostic modalities, the therapeutic alternatives and the risks to be known. Particularly, we detail the risks of oncologic transformation of these poorly known lesions.The management of these rare lesions is based on a collaboration between the surgeon and the dermatologist. PMID: 31729850 [PubMed - in process] {url} = URL to article
-
Related Articles Cutaneous pseudolymphoma with rhinophyma-like lesion. J Dermatol. 2019 09;46(9):e335-e337 Authors: Oginezawa M, Kawai K PMID: 30951205 [PubMed - indexed for MEDLINE] {url} = URL to article
-
Related Articles Topical treatments for rosacea. Can Fam Physician. 2019 Nov;65(11):803 Authors: Fritsch P, Kolber MR, Korownyk C PMID: 31722913 [PubMed - in process] {url} = URL to article
-
